CR9021A - Nuevas sales de estroncio de acidos sulfonicos, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen - Google Patents

Nuevas sales de estroncio de acidos sulfonicos, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen

Info

Publication number
CR9021A
CR9021A CR9021A CR9021A CR9021A CR 9021 A CR9021 A CR 9021A CR 9021 A CR9021 A CR 9021A CR 9021 A CR9021 A CR 9021A CR 9021 A CR9021 A CR 9021A
Authority
CR
Costa Rica
Prior art keywords
stroncio
new
pharmaceutical compositions
sulfonic acid
compositions containing
Prior art date
Application number
CR9021A
Other languages
English (en)
Inventor
Lefoulon Francois
Rolland Yves
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CR9021A publication Critical patent/CR9021A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/05—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing at least two sulfo groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/17—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/46—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Sales de estroncio de los acidos sulfonicos de la formula (I): A-B-SO3H en la que: A representa un grupo elegido entre OH, NH2, SO3H y CO2H, y B representa un grupo arileno o una cadena de alquileno lineal o ramificada C1-C12 eventualmente sustituida y donde uno o varios de los atomos de carbono esta eventualmente reemplazado por un atomo de oxigeno, nitrogeno o un grupo SO2.
CR9021A 2006-04-12 2007-03-28 Nuevas sales de estroncio de acidos sulfonicos, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen CR9021A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603224A FR2899895B1 (fr) 2006-04-12 2006-04-12 Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
CR9021A true CR9021A (es) 2007-08-28

Family

ID=37487610

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9021A CR9021A (es) 2006-04-12 2007-03-28 Nuevas sales de estroncio de acidos sulfonicos, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen

Country Status (32)

Country Link
US (1) US7999009B2 (es)
EP (1) EP1845082A1 (es)
JP (1) JP4584952B2 (es)
KR (1) KR100878100B1 (es)
CN (1) CN101054352B (es)
AP (1) AP2133A (es)
AR (1) AR060426A1 (es)
AU (1) AU2007201607A1 (es)
BR (1) BRPI0701535A (es)
CA (1) CA2584083C (es)
CO (1) CO5840250A1 (es)
CR (1) CR9021A (es)
EA (1) EA011440B1 (es)
FR (1) FR2899895B1 (es)
GE (1) GEP20094657B (es)
GT (1) GT200700030A (es)
HK (1) HK1108315A1 (es)
IL (1) IL182458A0 (es)
MA (1) MA28990B1 (es)
MX (1) MX2007004291A (es)
MY (1) MY146821A (es)
NO (1) NO20071857L (es)
NZ (1) NZ554433A (es)
PE (1) PE20080128A1 (es)
SA (1) SA07280169B1 (es)
SG (1) SG136883A1 (es)
TN (1) TNSN07116A1 (es)
TW (1) TW200815327A (es)
UA (1) UA96120C2 (es)
UY (1) UY30261A1 (es)
WO (1) WO2007116149A1 (es)
ZA (1) ZA200703012B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010054485A1 (en) * 2008-11-14 2010-05-20 Bellus Health (International) Limited Organic nutrient salts, methods of preparation and uses
FR2953139B1 (fr) 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236708A (en) * 1963-04-24 1966-02-22 Fmc Corp Etching of metals
CA1111050A (en) * 1977-06-23 1981-10-20 Feike De Jong Macrocyclic polyether complexes
JPH0822985B2 (ja) * 1987-10-16 1996-03-06 東洋インキ製造株式会社 グラビアインキ用アゾ顔料組成物
JPH01282313A (ja) * 1988-05-10 1989-11-14 Asahi Chem Ind Co Ltd 炭素繊維の製造方法
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
CA2215647A1 (en) * 1996-10-24 1998-04-24 Eli Lilly And Company Naphthyl compounds, compositions, and methods
PT1051393E (pt) * 1998-01-27 2004-02-27 Merck Sante Sas Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos
ATE271540T1 (de) * 1999-01-27 2004-08-15 Wyeth Corp Acetylenische arylsulfonamid- und phosphinsäureamid-hydroxamsäure-derivate als tace inhibitoren
JP2002234868A (ja) * 2001-02-08 2002-08-23 Rekkutekku Laboratories Kk アシルタウリン塩の製造方法
DK2266584T3 (da) * 2003-05-07 2013-01-02 Osteologix As Sammensætning med strontium og D-vitamin til profylakse og/eller behandling af brusk- og knogletilstande
US7335686B2 (en) * 2003-10-20 2008-02-26 Council Of Scientific And Industrial Research Method and composition for treating osteoporosis

Also Published As

Publication number Publication date
TW200815327A (en) 2008-04-01
ZA200703012B (en) 2008-07-30
GT200700030A (es) 2007-12-10
CO5840250A1 (es) 2007-12-31
KR100878100B1 (ko) 2009-01-14
TNSN07116A1 (fr) 2008-06-02
NZ554433A (en) 2008-08-29
CA2584083C (fr) 2011-01-04
MA28990B1 (fr) 2007-11-01
BRPI0701535A (pt) 2008-04-01
MY146821A (en) 2012-09-28
CN101054352A (zh) 2007-10-17
AP2007003954A0 (en) 2007-04-30
UY30261A1 (es) 2007-05-31
FR2899895B1 (fr) 2010-09-17
EA011440B1 (ru) 2009-02-27
SA07280169B1 (ar) 2011-04-05
JP4584952B2 (ja) 2010-11-24
PE20080128A1 (es) 2008-03-29
GEP20094657B (en) 2009-03-25
UA96120C2 (ru) 2011-10-10
HK1108315A1 (en) 2008-05-02
CA2584083A1 (fr) 2007-10-12
EP1845082A1 (fr) 2007-10-17
AP2133A (en) 2010-07-12
WO2007116149A1 (fr) 2007-10-18
AU2007201607A1 (en) 2007-11-01
US7999009B2 (en) 2011-08-16
JP2007302654A (ja) 2007-11-22
NO20071857L (no) 2007-10-15
AR060426A1 (es) 2008-06-18
KR20070101795A (ko) 2007-10-17
EA200700618A3 (ru) 2008-02-28
FR2899895A1 (fr) 2007-10-19
IL182458A0 (en) 2008-01-20
MX2007004291A (es) 2009-02-16
EA200700618A2 (ru) 2007-10-26
CN101054352B (zh) 2011-05-11
US20070244191A1 (en) 2007-10-18
SG136883A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
AR033620A1 (es) Compuestos de sulfonilo de alfa-aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR064731A1 (es) Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk
AR058348A1 (es) Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden
CO6280485A2 (es) Inhibidores de 11-beta hidroxiesteroide deshidrogenasa tipo i de triazolopiridina
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
AR064732A1 (es) Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk
AR048641A1 (es) Compuestos de aril- o heteroarilamida ortosustituidos utiles como antago-nistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicame
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
NI201000134A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PA8768301A1 (es) Nuevos derivados tricíclicos, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen
CR9499A (es) Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CR9021A (es) Nuevas sales de estroncio de acidos sulfonicos, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
CU20070071A7 (es) Nuevas sales de estroncio de ácidos sulfónicos, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
ATE511837T1 (de) Wässrige arzneimittelformulierung von 4-ä((4- carboxybutyl)-ä2-ä(4-phenethyl-benzyl)oxyü- phenethylüamino)methylübenzoesäure
SV2006002355A (es) Formulaciones inyectables o administrables por via oral de derivados de azetidina
SV2010003511A (es) Nuevas sales de adicion de inhibidores de la enzima de conversion de la angiotensina a acidos donadores de no, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
AR031662A1 (es) Nuevos derivados biciclicos de aminopirazinonas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y su utilizacion como inhibidores de proteasas de serina relacionadas con la tripsina
CR11494A (es) Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CU20120041A7 (es) Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY29347A1 (es) Nuevos derivados de diarilo del ácido acético y la preparación de los mismos.
CR11567A (es) Nuevos compuestos piperidinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CO6280059A1 (es) Nuevos derivados de azabiciclos (3.2.0) hept-3-ilo su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CU20070216A7 (es) Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)